TITLE

CHANGES IN QUALITY OF LIFE AND COGNITIVE FUNCTION FOLLOWING IRON THERAPY TO TREAT ANAEMIA IN A POPULATION OF IRD PATIENTS IN A BRITISH DISTRICT GENERAL HOSPITAL

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA103
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Anaemia commonly complicates inflammatory bowel disease (IBD). Improvements in I-lb will improve quality of life scores in IBD patients independent of changes in disease activity. Researchers found no similar effect with CF. We found no evidence that iron treatment caused worsening of disease activity. They therefore advocate further research to investigate the optimal treatment of anaemia in the management of IBD, with specific studies designed to validate our finding that iron can be used solely.
ACCESSION #
13219217

 

Related Articles

  • Factors affecting health related quality of life of patients with inflammatory bowel disease. Casellas, Francesc; López-Vivancos, Josefa; Casado, Alfonso; Malagelada, Juan-Ramon // Quality of Life Research;Dec2002, Vol. 11 Issue 8, p775 

    Using a disease specific instrument to measure the health related quality of life (HRQOL) of patients with inflammatory bowel disease (IBD), it has been shown that their perceived HRQOL worsens during active disease. The precise factors involved in HRQOL changes reported by these patients are...

  • Cross-Cultural Variation in Disease-Related Concerns Among Patients With Inflammatory Bowel Disease. Levenstein, Susan; Zhiming Li; Almer, Sven; Barbosa, Antonio; Marquis, Patrick; Moser, Gabriele; Sperber, Ami; Toner, Brenda; Drossman, Douglas A. // American Journal of Gastroenterology;Jun2001, Vol. 96 Issue 6, p1822 

    OBJECTIVE: The aim of this work was to study cross-cultural variations in the impact of inflammatory bowel disease (IBD) on health-related quality of life by an international comparison of disease-related concerns. METHODS: Item and factor scores on the Rating Form of Inflammatory Bowel Disease...

  • Questions on life satisfaction (FLZM) in inflammatory bowel disease. Janke, K.-H.; Raible, A.; Bauer, M.; Clemens, P.; Meisner, C.; Häuser, W.; Steder-Neukamm, U.; Henrich, G.; Herschbach, P.; Gregor, M.; Klump, B. // International Journal of Colorectal Disease;Jul2004, Vol. 19 Issue 4, p343 

    Background and aims. When assessing quality of care the outcome in terms of quality of life (QOL) is of major significance. This study examined QOL in IBD outpatients and the contribution of individual expectations and various other factors including disease activity. Patients and methods. The...

  • Intravenous iron in inflammatory bowel disease. Muñoz, Manuel; Gómez-Ramírez, Susana; García-Erce, José Antonio; Annibale, Bruno // World Journal of Gastroenterology;10/7/2009, Vol. 15 Issue 37, p4666 

    The prevalence of anemia across studies on patients with inflammatory bowel disease (IBD) is high (30%). Both iron deficiency (ID) and anemia of chronic disease contribute most to the development of anemia in IBD. The prevalence of ID is even higher (45%). Anemia and ID negatively impact the...

  • Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.  // Inflammatory Bowel Disease Monitor;2014, Vol. 14 Issue 2, p63 

    Befrits and colleagues summarized the experience with using ferric carboxymaltose (FCM) for the treatment of iron-deficiency anemia in 394 adults with IBD (60% Crohn's disease, 40% ulcerative colitis) in Sweden. They report a significant improvement in serum iron indices and quality of life...

  • If at First You Don't Succeed .. Try Again? Kane, Sunanda; Johnson, David // American Journal of Gastroenterology;Jul2001, Vol. 96 Issue 7, p2260 

    The histories of patients prescribed 6-mercaptopurine over a 2-yr time were examined. Those patients who had initially failed azathioprine therapy before initiating 6-mercaptopurine were included in the study. Clinical data were collected from medical records as well as from patient interviews....

  • Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Powell, Jonathan J.; Cook, William B.; Hutchinson, Carol; Tolkien, Zoe; Chatfield, Mark; Pereira, Dora I. A.; Lomer, Miranda C. E. // Nutrition & Metabolism;2013, Vol. 10 Issue 1, p9 

    Background: Iron deficiency anaemia and oral iron supplementation have been associated negatively with quality of life, and with adverse effects, respectively, in subjects with inflammatory bowel disease (IBD). Hence, the risk-benefit ratio of oral iron is not understood in this patient group....

  • A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Kennedy, A. P.; Nelson, E.; Reeves, D.; Richardson, G.; Roberts, C.; Robinson, A.; Rogers, A. E.; Sculpher, M.; Thompson, D. G. // Gut;Dec2004, Vol. 53 Issue 12, p1639 

    Objectives: We developed a patient centred approach to chronic disease sell management by providing information designed to promote patient choice. We then conducted a randomised controlled trial of the approach in inflammatory bowel disease (IBD) to assess whether it could alter clinical...

  • Do inflammatory bowel disease patients with anxiety and depressive symptoms receive the care they need?  // Inflammatory Bowel Disease Monitor;2012, Vol. 12 Issue 4, p154 

    The authors discuss the study that investigates the psychological symptoms in patients with inflammatory bowel disease (IBD). They state that the assumption where patients with anxiety and depressive symptoms were not provided with the care they needed has influenced to conduct the study. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics